Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors
Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four...
Saved in:
Published in | Journal of cataract and refractive surgery Vol. 33; no. 6; pp. 978 - 988 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.06.2007
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. Methods A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Results Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Conclusions Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs. |
---|---|
AbstractList | To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study.
Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom.
A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 x 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated.
Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8).
Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs. PURPOSETo identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study.SETTINGTwenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom.METHODSA prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 x 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated.RESULTSTwenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8).CONCLUSIONSUse of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs. To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs. Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on analysis of the findings of the European Society of Cataract & Refractive Surgeons (ESCRS) multicenter study. Setting Twenty-four ophthalmology units in Austria, Belgium, Germany, Italy, Poland, Portugal, Spain, Turkey, and the United Kingdom. Methods A prospective randomized partially masked multicenter cataract surgery study recruited 16 603 patients. The study was based on a 2 × 2 factorial design, with intracameral cefuroxime and topical perioperative levofloxacin factors resulting in 4 treatment groups. The comparison of case and non-case data was performed using multivariable logistic regression analyses. Odds ratios (ORs) associated with treatment effects and other risk factors were estimated. Results Twenty-nine patients presented with endophthalmitis, of whom 20 were classified as having proven infective endophthalmitis. The absence of an intracameral cefuroxime prophylactic regimen at 1 mg in 0.1 mL normal saline was associated with a 4.92-fold increase (95% confidence interval [CI], 1.87-12.9) in the risk for total postoperative endophthalmitis. In addition, the use of clear corneal incisions (CCIs) compared to scleral tunnels was associated with a 5.88-fold increase (95% CI, 1.34-25.9) in risk and the use of silicone intraocular lens (IOL) optic material compared to acrylic with a 3.13-fold increase (95% CI, 1.47-6.67). The presence of surgical complications increased the risk for total endophthalmitis 4.95-fold (95% CI, 1.68-14.6), and more experienced surgeons were more likely to be associated with endophthalmitis cases. When considering only proven infective endophthalmitis cases, the absence of cefuroxime and the use of silicone IOL optic material were significantly associated with an increased risk, and there was evidence that men were more predisposed to infection (OR, 2.70; 95% CI, 1.07-6.8). Conclusions Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis. Additional risk factors associated with endophthalmitis after cataract surgery included CCIs and the use of silicone IOLs. |
Author | ESCRS Endophthalmitis Study Group |
AuthorAffiliation | European Society of Cataract & Refractive Surgeons, Dublin, Ireland. escrs@agenda.com |
AuthorAffiliation_xml | – name: European Society of Cataract & Refractive Surgeons, Dublin, Ireland. escrs@agenda.com |
Author_xml | – sequence: 1 fullname: ESCRS Endophthalmitis Study Group |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18837796$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17531690$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl-LEzEUxYOsuN3VL-CD5EXfWjOTyWRGRJCy_oEFZavPIU3ubNNNk5qbWe3X8BObsYUFH3wK3PzO4XLOvSBnIQYg5HnFFhWr2tfbxdYkXNSMyQWrF4zXj8is6iSfN4LVZ2TGuq6dcy7YOblA3DLGmpqLJ-S8koJXbc9m5PfXFPebg9e_HNI40H3EHPeQdHb3QCHY8ps32u9cLsAQvY8_XbilRmedtMkUx3QL6fCG3gCOPv81yRugV6vlzYruysgZCBkSxTzaA9XBUmfLxA2umLgYJkVyeEeH4hcTPiWPB-0Rnp3eS_L9w9W35af59ZePn5fvr-dGNH2eSz70VgAM0kro-sYK2bYAtekrWHc9Xxthe93KddMwxju-Bq573tbcNKwBWfNL8urou0_xxwiY1c6hAe91gDiikkwIUUlewPoImhQREwxqn9xOp4OqmJqaUFs1NaGmJhSrVWmiiF6c3Mf1DuyD5BR9AV6eAI1G-yHpYBw-cF3Hpezbwr09clCyuHeQFBoHwYB1CUxWNrr_7_HuH7nxLpTo_R0cALdxTKGkrCqFRaBW081MJ8NkuZaW9fwPQMbBfQ |
CODEN | JCSUEV |
CitedBy_id | crossref_primary_10_1016_j_jcrs_2008_01_001 crossref_primary_10_1186_s12886_021_02175_z crossref_primary_10_1111_ceo_12932 crossref_primary_10_1099_jmm_0_026609_0 crossref_primary_10_1016_j_ophtha_2016_02_040 crossref_primary_10_1016_j_ophtha_2017_11_018 crossref_primary_10_1038_eye_2015_271 crossref_primary_10_1097_ICU_0000000000000115 crossref_primary_10_1016_j_jcrs_2012_03_024 crossref_primary_10_1177_11206721221145055 crossref_primary_10_1016_j_jcrs_2011_01_019 crossref_primary_10_1016_j_jcrs_2013_05_036 crossref_primary_10_1097_ICU_0b013e3283414fb3 crossref_primary_10_1007_s12325_016_0307_8 crossref_primary_10_1016_j_jcrs_2015_01_014 crossref_primary_10_1007_s00417_019_04417_9 crossref_primary_10_1055_a_1758_3451 crossref_primary_10_1016_S0140_6736_17_30544_5 crossref_primary_10_1097_IAE_0000000000001052 crossref_primary_10_1016_j_oret_2020_09_010 crossref_primary_10_1016_j_ejpb_2017_08_006 crossref_primary_10_1097_APO_0b013e31823e574b crossref_primary_10_7759_cureus_42662 crossref_primary_10_1155_2023_3132866 crossref_primary_10_1016_j_jcrs_2018_07_055 crossref_primary_10_3109_09273948_2015_1075559 crossref_primary_10_4103_2320_3897_183726 crossref_primary_10_1016_j_biomaterials_2012_07_052 crossref_primary_10_1111_j_1444_0938_2010_00516_x crossref_primary_10_1186_s40942_021_00280_1 crossref_primary_10_1136_bcr_2021_247772 crossref_primary_10_1007_s40123_021_00435_1 crossref_primary_10_3346_jkms_2018_33_e180 crossref_primary_10_1016_j_ajo_2012_06_024 crossref_primary_10_1016_j_jcrs_2011_08_038 crossref_primary_10_1016_j_ijpharm_2010_07_009 crossref_primary_10_1016_j_oftale_2014_01_007 crossref_primary_10_1097_IAE_0b013e31819d2591 crossref_primary_10_1080_02713683_2016_1256414 crossref_primary_10_1089_jop_2016_0019 crossref_primary_10_1016_j_jcrs_2007_07_009 crossref_primary_10_1016_j_jcrs_2016_11_048 crossref_primary_10_2146_ajhp120568 crossref_primary_10_4236_ojoph_2015_52008 crossref_primary_10_1111_j_1442_9071_2008_01869_x crossref_primary_10_4103_ejos_ejos_85_23 crossref_primary_10_1080_02713680802382971 crossref_primary_10_1155_2018_8567912 crossref_primary_10_3109_03639045_2015_1038273 crossref_primary_10_1016_j_jfo_2014_11_005 crossref_primary_10_1080_17469899_2017_1318065 crossref_primary_10_1155_2015_813697 crossref_primary_10_1186_1471_2415_12_2 crossref_primary_10_1016_S1283_0771_20_43269_4 crossref_primary_10_3390_biomedicines10081920 crossref_primary_10_1016_j_ajo_2016_06_012 crossref_primary_10_1097_j_jcrs_0000000000001151 crossref_primary_10_1097_ICU_0b013e32835b0716 crossref_primary_10_1007_s40123_023_00835_5 crossref_primary_10_1016_j_jcro_2016_10_004 crossref_primary_10_1097_IPC_0b013e318184d77a crossref_primary_10_3109_08820530903389692 crossref_primary_10_1111_aos_15732 crossref_primary_10_1016_j_ajo_2018_01_030 crossref_primary_10_1111_aos_13314 crossref_primary_10_1016_j_jcrs_2009_05_061 crossref_primary_10_1016_j_ophtha_2016_08_035 crossref_primary_10_1016_j_ajo_2018_03_042 crossref_primary_10_1016_j_jhin_2011_02_004 crossref_primary_10_1111_j_1755_3768_2008_01358_x crossref_primary_10_1016_j_jcrs_2009_02_001 crossref_primary_10_1016_j_jfo_2011_05_002 crossref_primary_10_1038_s41433_019_0758_7 crossref_primary_10_1016_j_ajo_2021_02_007 crossref_primary_10_1111_ceo_12847 crossref_primary_10_3390_jcm10051059 crossref_primary_10_1016_j_jcrs_2016_02_026 crossref_primary_10_1177_11206721221124673 crossref_primary_10_1016_j_jcrs_2016_09_013 crossref_primary_10_1016_j_jcrs_2009_03_049 crossref_primary_10_1371_journal_pone_0156856 crossref_primary_10_1136_bcr_2021_246985 crossref_primary_10_1016_j_jfo_2011_05_007 crossref_primary_10_1111_aos_12221 crossref_primary_10_1038_eye_2008_173 crossref_primary_10_1038_eye_2008_295 crossref_primary_10_1007_s10792_022_02508_x crossref_primary_10_1097_APO_0b013e31826cd8f2 crossref_primary_10_1371_journal_pone_0110872 crossref_primary_10_1038_eye_2012_40 crossref_primary_10_3390_pharmaceutics12060572 crossref_primary_10_1007_s40135_018_0171_6 crossref_primary_10_1016_S2173_5794_10_70051_7 crossref_primary_10_1016_j_jcrs_2008_02_013 crossref_primary_10_1016_j_ajic_2013_01_042 crossref_primary_10_1038_s41598_022_21423_w crossref_primary_10_2147_IDR_S252674 crossref_primary_10_1080_15569527_2020_1813748 crossref_primary_10_1016_S0929_693X_13_71412_X crossref_primary_10_1586_17469899_3_1_17 crossref_primary_10_1155_2019_5746186 crossref_primary_10_1111_j_1442_9071_2010_02402_x crossref_primary_10_1016_j_jcrs_2014_07_011 crossref_primary_10_1080_17469899_2021_1962296 crossref_primary_10_1007_s10384_009_0718_z crossref_primary_10_1080_02713683_2019_1701686 crossref_primary_10_1016_j_jcrs_2016_11_007 crossref_primary_10_1016_S1283_0771_10_70260_7 crossref_primary_10_1155_2021_5526097 crossref_primary_10_3928_01913913_20170823_02 crossref_primary_10_3109_02713683_2012_763101 crossref_primary_10_1016_j_jhin_2013_05_009 crossref_primary_10_1089_jop_2012_0062 crossref_primary_10_1111_aos_12684 crossref_primary_10_1007_s10792_016_0279_3 crossref_primary_10_1016_j_jfo_2022_12_028 crossref_primary_10_1016_j_jcrs_2016_12_025 crossref_primary_10_7759_cureus_53532 crossref_primary_10_1111_ceo_12524 crossref_primary_10_1111_ceo_13737 crossref_primary_10_1016_j_ajo_2023_11_003 crossref_primary_10_1097_IAE_0000000000003570 crossref_primary_10_1016_j_ophtha_2016_02_019 crossref_primary_10_1097_IAE_0b013e3182947b29 crossref_primary_10_1007_s00417_015_3009_z crossref_primary_10_4137_OED_S4866 crossref_primary_10_1038_s41433_020_0869_1 crossref_primary_10_18410_jebmh_2021_495 crossref_primary_10_3238_arztebl_2009_0695 crossref_primary_10_1016_j_mexoft_2014_09_007 crossref_primary_10_1007_s10792_014_0017_7 crossref_primary_10_1186_1471_2415_14_57 crossref_primary_10_1007_s10792_016_0307_3 crossref_primary_10_1016_j_jfo_2013_06_007 crossref_primary_10_1016_j_mexoft_2014_09_004 crossref_primary_10_1016_j_jcrs_2008_04_058 crossref_primary_10_17925_USOR_2018_11_1_15 crossref_primary_10_1016_j_oftale_2014_06_004 crossref_primary_10_1016_j_jcrs_2013_11_023 crossref_primary_10_1016_j_oftale_2020_12_011 crossref_primary_10_1016_j_jcrs_2014_05_033 crossref_primary_10_17816_OV10162_69 crossref_primary_10_1007_s40123_021_00406_6 crossref_primary_10_1016_j_farma_2011_07_003 crossref_primary_10_1016_j_jcrs_2014_05_038 crossref_primary_10_1097_ICO_0b013e318191447b crossref_primary_10_5005_hoo_10101_41605 crossref_primary_10_1111_j_1755_3768_2011_02324_x crossref_primary_10_1016_j_yaoo_2018_05_005 crossref_primary_10_1038_s41433_020_01303_1 crossref_primary_10_1186_1471_2415_13_71 crossref_primary_10_4103_ojo_OJO_249_2020 crossref_primary_10_1016_j_ophtha_2012_07_013 crossref_primary_10_4265_bio_15_97 crossref_primary_10_1007_s00347_007_1624_8 crossref_primary_10_1007_s00347_014_3032_1 crossref_primary_10_1136_ejhpharm_2013_000307 crossref_primary_10_1159_000441662 crossref_primary_10_1016_j_ijpharm_2021_121185 crossref_primary_10_1089_jop_2008_0102 crossref_primary_10_1016_j_jcrs_2008_03_017 crossref_primary_10_1002_pds_4149 crossref_primary_10_1016_j_ophtha_2016_03_024 crossref_primary_10_1016_j_oret_2022_03_009 crossref_primary_10_1016_j_ophtha_2016_04_039 crossref_primary_10_1007_s10156_009_0687_7 crossref_primary_10_1111_j_1755_3768_2008_01441_x crossref_primary_10_1111_vop_13023 crossref_primary_10_1016_S0246_0343_08_44080_7 crossref_primary_10_1016_j_survophthal_2020_10_006 crossref_primary_10_1186_s12886_019_1028_y crossref_primary_10_1016_j_ophtha_2021_10_006 crossref_primary_10_5301_ejo_5000473 crossref_primary_10_1097_IAE_0000000000001583 crossref_primary_10_1016_j_jcrs_2009_05_039 crossref_primary_10_1016_j_jcrs_2013_11_046 crossref_primary_10_1155_2017_1261698 crossref_primary_10_1016_j_ophtha_2014_03_032 crossref_primary_10_1016_j_ajo_2016_04_013 crossref_primary_10_1016_j_jcrs_2008_03_021 crossref_primary_10_1111_aos_14018 crossref_primary_10_1016_j_jcrs_2019_03_027 crossref_primary_10_1007_s40135_018_0174_3 crossref_primary_10_3390_antibiotics12081246 crossref_primary_10_1016_j_jcro_2014_05_002 crossref_primary_10_4137_OED_S13102 crossref_primary_10_1007_s15010_008_8150_8 crossref_primary_10_1177_0018578718757516 crossref_primary_10_1016_j_jcrs_2018_10_044 crossref_primary_10_3390_bioengineering7030065 crossref_primary_10_1016_j_jcrs_2015_11_010 crossref_primary_10_1007_s40123_023_00661_9 crossref_primary_10_1586_17469899_2_2_213 crossref_primary_10_1016_j_jcrs_2007_10_041 crossref_primary_10_1016_j_jcrs_2011_07_013 crossref_primary_10_1016_j_jhin_2011_07_009 crossref_primary_10_1016_j_jcrs_2014_06_042 crossref_primary_10_1080_17469899_2019_1674140 crossref_primary_10_3928_23258160_20221026_03 crossref_primary_10_1016_j_jcrs_2009_12_013 crossref_primary_10_1016_j_jcrs_2010_08_047 crossref_primary_10_1080_17469899_2017_1302798 crossref_primary_10_1586_17469899_2015_1088782 crossref_primary_10_1002_14651858_CD013270_pub2 crossref_primary_10_1136_bjophthalmol_2013_304485 crossref_primary_10_12677_acm_2024_1441170 crossref_primary_10_1038_eye_2010_39 crossref_primary_10_12968_ijop_2014_5_5_167 crossref_primary_10_1007_s40135_013_0020_6 crossref_primary_10_1007_s15010_011_0138_0 crossref_primary_10_1007_s00347_013_2904_0 crossref_primary_10_1016_S0084_392X_08_79175_5 crossref_primary_10_1007_s00347_010_2219_3 crossref_primary_10_5005_hov_10102_06201 crossref_primary_10_1016_j_oftal_2010_11_005 crossref_primary_10_1016_j_jcrs_2014_10_010 crossref_primary_10_1016_j_ophtha_2016_11_042 crossref_primary_10_3389_fcimb_2023_1172345 crossref_primary_10_1016_j_ajoc_2020_100903 crossref_primary_10_1155_2020_7242969 crossref_primary_10_1016_j_ajoc_2020_100905 crossref_primary_10_1016_j_jcrs_2015_06_031 crossref_primary_10_1016_j_jcrs_2010_08_051 crossref_primary_10_1093_jac_dkr009 crossref_primary_10_3129_i08_133 crossref_primary_10_12968_ijop_2012_3_1_4 crossref_primary_10_1016_j_jcrs_2008_05_043 crossref_primary_10_1055_s_0043_1771043 crossref_primary_10_1016_S0084_392X_10_79348_5 crossref_primary_10_1016_j_jcrs_2012_09_004 crossref_primary_10_1016_j_jcrs_2008_05_045 crossref_primary_10_3928_23258160_20180501_12 crossref_primary_10_5005_hos_10101_41501 crossref_primary_10_1097_APO_0b013e31823e4c1e crossref_primary_10_3390_toxins11060356 crossref_primary_10_1111_ceo_12910 crossref_primary_10_5005_hoo_10101_41501 crossref_primary_10_2147_IDR_S304675 crossref_primary_10_1080_17469899_2023_2264508 crossref_primary_10_1016_j_ophtha_2011_11_023 crossref_primary_10_1007_s10792_021_02142_z crossref_primary_10_4236_ojoph_2020_101004 crossref_primary_10_1007_s10792_015_0151_x crossref_primary_10_1016_j_ajo_2010_04_010 crossref_primary_10_1080_09273948_2022_2152699 crossref_primary_10_3341_jkos_2015_56_12_1854 crossref_primary_10_1177_112067210901900407 crossref_primary_10_3129_i08_144 crossref_primary_10_1016_j_jcrs_2019_04_018 crossref_primary_10_1016_j_jcrs_2014_05_050 crossref_primary_10_1016_j_preteyeres_2012_03_004 crossref_primary_10_1007_s40135_013_0021_5 crossref_primary_10_1007_s00417_018_3954_4 crossref_primary_10_1111_aos_12279 crossref_primary_10_1016_j_jcrs_2009_06_038 crossref_primary_10_1016_j_jcrs_2011_09_040 crossref_primary_10_1007_s10792_020_01457_7 crossref_primary_10_1016_j_ajo_2016_11_006 crossref_primary_10_1016_j_ophtha_2012_07_031 crossref_primary_10_1016_j_jcrs_2008_10_018 crossref_primary_10_1016_j_jcrs_2009_06_037 crossref_primary_10_1136_bcr_2020_239799 crossref_primary_10_1007_s40135_019_00224_x crossref_primary_10_1097_ICU_0000000000000907 crossref_primary_10_1111_aos_13121 crossref_primary_10_2147_OPTH_S458130 crossref_primary_10_1007_s10792_021_01967_y crossref_primary_10_1097_MD_0000000000008941 crossref_primary_10_1016_j_jfo_2009_11_010 crossref_primary_10_1111_aos_12827 crossref_primary_10_1089_jop_2014_0029 crossref_primary_10_1080_08820538_2017_1353826 crossref_primary_10_1016_j_ophtha_2015_03_016 crossref_primary_10_1016_j_jcrs_2015_04_006 crossref_primary_10_1155_2021_9985821 crossref_primary_10_1038_eye_2009_218 crossref_primary_10_1155_2011_982410 crossref_primary_10_1016_j_survophthal_2020_04_006 crossref_primary_10_1007_s00347_018_0729_6 crossref_primary_10_1586_eop_12_77 crossref_primary_10_1016_j_jcrs_2014_11_010 crossref_primary_10_1097_IAE_0000000000000513 crossref_primary_10_1097_IAE_0000000000001603 crossref_primary_10_1016_j_ajoc_2018_12_003 crossref_primary_10_5301_ejo_5000738 crossref_primary_10_1016_j_ajo_2013_04_025 crossref_primary_10_1016_j_jcrs_2010_12_050 crossref_primary_10_1016_j_ophtha_2015_03_003 crossref_primary_10_1016_j_ajo_2013_04_024 crossref_primary_10_1007_s00417_009_1085_7 crossref_primary_10_1016_j_jcrs_2010_03_008 crossref_primary_10_1186_s12886_015_0056_5 crossref_primary_10_3341_kjo_2015_29_1_7 crossref_primary_10_1016_j_jcrs_2016_07_022 crossref_primary_10_1097_j_jcrs_0000000000000757 crossref_primary_10_1055_a_1814_6033 crossref_primary_10_1097_j_jcrs_0000000000000516 crossref_primary_10_1177_1120672117747043 crossref_primary_10_1186_s12348_016_0115_y crossref_primary_10_1016_j_jcrs_2010_12_046 crossref_primary_10_1157_13128276 crossref_primary_10_1007_s00717_008_0239_z crossref_primary_10_1007_s00717_017_0350_0 crossref_primary_10_1038_eye_2017_85 crossref_primary_10_1016_j_jfo_2012_10_001 crossref_primary_10_1097_APO_0000000000000014 crossref_primary_10_4103_IJO_IJO_702_23 crossref_primary_10_1016_j_jcrs_2008_05_034 crossref_primary_10_1016_j_oftal_2020_12_018 crossref_primary_10_1016_j_jcrs_2007_12_025 crossref_primary_10_5301_ejo_5000642 crossref_primary_10_1016_j_jcrs_2012_07_038 crossref_primary_10_1002_14651858_CD006364_pub3 crossref_primary_10_1016_S1280_4703_20_43649_7 crossref_primary_10_1016_j_jcrs_2014_04_040 crossref_primary_10_1002_jcph_2451 crossref_primary_10_1016_j_jfo_2010_07_011 crossref_primary_10_1136_bmjophth_2020_000464 crossref_primary_10_1097_ICU_0b013e32834cd5a9 crossref_primary_10_3390_ijerph16122188 crossref_primary_10_1097_ICO_0000000000000441 crossref_primary_10_1586_17469899_2_5_803 crossref_primary_10_2147_OPTH_S459266 crossref_primary_10_1016_j_jcrs_2010_03_013 crossref_primary_10_1016_j_jcrs_2015_05_029 crossref_primary_10_1016_j_jcrs_2017_08_009 crossref_primary_10_1016_j_ophtha_2013_08_046 crossref_primary_10_1016_j_jfo_2009_04_026 crossref_primary_10_1016_S0008_4182_08_80002_6 crossref_primary_10_1016_j_jcrs_2012_07_031 crossref_primary_10_1007_s10096_010_0901_7 crossref_primary_10_1016_j_ophtha_2015_12_011 crossref_primary_10_1089_jop_2022_0144 crossref_primary_10_1016_j_jcrs_2009_08_034 crossref_primary_10_1016_j_jcrs_2010_04_030 crossref_primary_10_1016_j_ijpharm_2018_12_028 crossref_primary_10_4265_bio_17_93 crossref_primary_10_1007_s10792_018_0825_2 crossref_primary_10_1016_S0181_5512_07_79285_9 crossref_primary_10_1007_s00347_009_2027_9 crossref_primary_10_1097_APO_0000000000000151 crossref_primary_10_17116_oftalma2020136042258 crossref_primary_10_1177_11206721231200996 crossref_primary_10_1016_j_ophtha_2021_09_004 crossref_primary_10_1016_j_ajo_2016_02_001 crossref_primary_10_1038_s41598_023_45398_4 crossref_primary_10_3109_15569527_2014_918138 crossref_primary_10_1016_j_jcrs_2008_12_027 crossref_primary_10_1177_20420986241258049 crossref_primary_10_3390_microorganisms12040649 crossref_primary_10_1016_j_jcrs_2008_12_023 crossref_primary_10_1016_j_jcrs_2011_06_036 crossref_primary_10_1586_17469899_2014_951331 crossref_primary_10_1167_tvst_10_3_1 crossref_primary_10_1016_j_ajo_2016_08_024 crossref_primary_10_1016_j_oret_2019_03_009 crossref_primary_10_1016_j_oftal_2020_04_005 crossref_primary_10_1016_j_oftale_2016_07_003 crossref_primary_10_1155_2022_4857696 crossref_primary_10_5812_jjm_13108 crossref_primary_10_1097_ICU_0000000000000727 crossref_primary_10_1007_s11845_014_1127_y crossref_primary_10_1111_ceo_12199 crossref_primary_10_1016_j_jcrs_2014_02_006 crossref_primary_10_1016_j_ogla_2018_05_001 crossref_primary_10_1016_j_sapharm_2016_05_093 crossref_primary_10_7717_peerj_12305 crossref_primary_10_1016_j_jcrs_2010_10_007 crossref_primary_10_1016_j_jcrs_2007_11_027 crossref_primary_10_1097_j_jcrs_0000000000000559 crossref_primary_10_1016_j_survophthal_2017_04_004 crossref_primary_10_1007_s00417_014_2658_7 crossref_primary_10_1016_j_jcrs_2017_07_028 crossref_primary_10_1055_a_1488_0918 crossref_primary_10_1097_IAE_0000000000000727 crossref_primary_10_1097_j_jcrs_0000000000000672 crossref_primary_10_1016_S0246_0343_08_49001_9 crossref_primary_10_1016_j_jcrs_2009_08_023 crossref_primary_10_1556_650_2021_31941 crossref_primary_10_5301_ejo_5000964 crossref_primary_10_1016_j_oftal_2016_03_009 crossref_primary_10_1016_j_jfo_2016_11_006 crossref_primary_10_1097_APO_0b013e31823ff9de crossref_primary_10_1016_j_jcrs_2016_06_030 crossref_primary_10_1016_j_oftale_2015_06_006 crossref_primary_10_1111_1469_0691_12118 crossref_primary_10_1186_s12886_023_03003_2 crossref_primary_10_1016_j_jcrs_2011_06_018 crossref_primary_10_1111_aos_14175 crossref_primary_10_1097_ICU_0000000000000625 crossref_primary_10_1111_j_1442_9071_2010_02279_x crossref_primary_10_1016_j_jcrs_2019_06_009 crossref_primary_10_1038_s41433_021_01548_4 crossref_primary_10_1016_j_jcrs_2009_01_002 crossref_primary_10_22608_APO_201866 crossref_primary_10_1016_j_jcrs_2009_01_003 crossref_primary_10_1111_aos_12668 crossref_primary_10_1016_j_joco_2016_05_002 crossref_primary_10_1016_j_ophtha_2015_09_037 crossref_primary_10_1038_nrdp_2015_14 crossref_primary_10_1097_ICU_0b013e32835a93be crossref_primary_10_22608_APO_2017343 crossref_primary_10_1016_j_ajo_2015_09_028 crossref_primary_10_1007_s40123_018_0138_6 crossref_primary_10_3341_jkos_2017_58_6_663 crossref_primary_10_1001_jamaophthalmol_2024_1716 crossref_primary_10_1038_s41598_018_25030_6 crossref_primary_10_1097_j_jcrs_0000000000001305 crossref_primary_10_1016_j_oftal_2013_10_008 crossref_primary_10_1016_j_jcrs_2013_06_008 crossref_primary_10_1097_IIO_0000000000000327 crossref_primary_10_1097_j_jcrs_0000000000000697 crossref_primary_10_1111_ceo_13739 crossref_primary_10_1016_j_jcro_2018_08_001 crossref_primary_10_1016_j_ogla_2020_07_008 crossref_primary_10_1136_bjophthalmol_2014_306586 crossref_primary_10_1186_s12886_020_01615_6 crossref_primary_10_3341_kjo_2022_0014 crossref_primary_10_1111_ceo_13991 crossref_primary_10_1016_j_jcrs_2012_12_001 crossref_primary_10_1111_ceo_12789 crossref_primary_10_1002_cbdv_202301382 crossref_primary_10_1016_j_ajo_2013_05_018 crossref_primary_10_1097_IAE_0b013e3181953a31 crossref_primary_10_1016_j_ajo_2013_10_018 crossref_primary_10_1186_s40942_015_0010_y crossref_primary_10_2165_00003495_200969090_00009 crossref_primary_10_7759_cureus_19469 crossref_primary_10_1016_j_jcrs_2018_05_022 crossref_primary_10_1016_j_jcrs_2012_05_024 crossref_primary_10_1097_j_jcrs_0000000000000563 crossref_primary_10_2147_OPTH_S422502 crossref_primary_10_1016_j_vhri_2020_01_007 crossref_primary_10_1155_2015_912481 crossref_primary_10_1016_j_jcrs_2018_12_019 crossref_primary_10_1136_bmjophth_2020_000635 crossref_primary_10_1097_APO_0000000000000415 crossref_primary_10_1038_s41598_020_71050_6 crossref_primary_10_1590_S0080_62342012000300010 crossref_primary_10_22608_APO_2017200 crossref_primary_10_1007_s40265_013_0011_9 crossref_primary_10_1016_j_preteyeres_2016_04_007 crossref_primary_10_1089_sur_2013_9999 crossref_primary_10_1016_j_oret_2020_11_015 crossref_primary_10_1016_j_oftal_2010_07_006 crossref_primary_10_1007_s10384_017_0545_6 crossref_primary_10_1097_j_jcrs_0000000000000599 crossref_primary_10_1016_j_oftal_2013_06_007 crossref_primary_10_5005_highlights_44_1_11 crossref_primary_10_1016_j_jcrs_2010_01_030 crossref_primary_10_1097_ICB_0000000000000725 crossref_primary_10_1016_j_jcrs_2019_07_022 crossref_primary_10_1016_j_ophtha_2017_01_026 crossref_primary_10_1007_s10792_021_01830_0 crossref_primary_10_1111_ceo_13890 crossref_primary_10_1371_journal_pone_0189778 crossref_primary_10_1016_j_ajo_2010_08_044 crossref_primary_10_1016_S0246_0289_10_44761_1 crossref_primary_10_2144_fsoa_2022_0076 crossref_primary_10_1016_S0716_8640_10_70615_5 crossref_primary_10_1177_1120672120963458 crossref_primary_10_1007_s00417_013_2294_7 crossref_primary_10_1016_j_jcrs_2013_06_014 crossref_primary_10_1097_IIO_0000000000000122 crossref_primary_10_1155_2016_9186351 crossref_primary_10_1136_bmjopen_2018_027036 crossref_primary_10_1016_j_jcrs_2019_07_016 crossref_primary_10_1038_s41433_021_01886_3 crossref_primary_10_1007_s00417_015_3188_7 crossref_primary_10_1016_j_jcrs_2011_03_032 crossref_primary_10_1016_j_jcrs_2014_08_027 crossref_primary_10_1016_j_oftale_2020_04_019 crossref_primary_10_1007_s10792_023_02816_w crossref_primary_10_1097_01_APO_0000617904_11979_ae crossref_primary_10_1007_s00417_017_3686_x crossref_primary_10_1007_s00417_021_05084_5 crossref_primary_10_2147_IDR_S332997 crossref_primary_10_1016_j_ophtha_2017_01_038 crossref_primary_10_5402_2011_917265 crossref_primary_10_1016_j_jcrs_2011_03_031 crossref_primary_10_1186_s12911_023_02214_3 crossref_primary_10_1007_s10792_012_9537_1 crossref_primary_10_1128_mSphere_00335_17 crossref_primary_10_1007_s10384_010_0838_5 crossref_primary_10_1097_IEB_0b013e3181c70f93 crossref_primary_10_1080_09273948_2023_2170249 crossref_primary_10_3390_jcm10163611 crossref_primary_10_1016_j_jfo_2012_09_010 crossref_primary_10_3341_jkos_2016_57_3_420 crossref_primary_10_1007_s00417_012_2098_1 crossref_primary_10_1007_s00417_010_1501_z crossref_primary_10_1016_j_jcrs_2008_08_036 crossref_primary_10_1111_iwj_13984 crossref_primary_10_54393_pjhs_v4i08_934 crossref_primary_10_1016_j_jcrs_2007_06_026 crossref_primary_10_1097_j_jcrs_0000000000000018 crossref_primary_10_1038_eye_2013_103 crossref_primary_10_1016_j_ophtha_2015_08_039 crossref_primary_10_1038_eye_2008_208 crossref_primary_10_1111_ceo_13419 crossref_primary_10_1016_j_jcrs_2015_02_026 crossref_primary_10_1097_ICU_0b013e32831b6daf crossref_primary_10_1016_j_jcrs_2015_02_027 crossref_primary_10_1016_j_jmii_2018_12_011 crossref_primary_10_1016_j_joco_2017_12_004 crossref_primary_10_1007_s00717_016_0306_9 crossref_primary_10_1016_j_jcrs_2015_02_028 crossref_primary_10_1016_j_jfo_2015_05_007 crossref_primary_10_1097_IIO_0000000000000409 crossref_primary_10_1007_s10384_021_00899_5 crossref_primary_10_1016_j_jcrs_2008_08_022 crossref_primary_10_1016_j_ajoint_2024_100034 crossref_primary_10_1136_bjophthalmol_2017_311051 crossref_primary_10_1002_jcph_634 crossref_primary_10_1016_j_jcrs_2013_08_062 crossref_primary_10_1016_j_ophtha_2017_02_019 crossref_primary_10_1016_j_ophtha_2020_06_034 crossref_primary_10_1016_j_jcrs_2016_10_017 crossref_primary_10_1016_j_colsurfb_2017_04_060 crossref_primary_10_1016_S2173_5794_10_70044_X crossref_primary_10_12968_opti_2017_3_152186 crossref_primary_10_1097_ICU_0000000000000445 crossref_primary_10_1097_ICU_0b013e32834cd5d1 crossref_primary_10_1136_bjophthalmol_2014_306372 crossref_primary_10_1097_ICU_0000000000000326 crossref_primary_10_1111_j_1755_3768_2012_02480_x crossref_primary_10_1097_j_jcrs_0000000000000245 crossref_primary_10_1016_j_ophtha_2015_08_023 crossref_primary_10_1097_j_jcrs_0000000000000241 crossref_primary_10_1136_bmjophth_2020_000609 crossref_primary_10_1016_j_jconrel_2020_07_020 crossref_primary_10_1097_j_jcrs_0000000000000365 crossref_primary_10_1016_j_jcrs_2007_07_058 crossref_primary_10_1007_s00347_011_2456_0 crossref_primary_10_1016_j_ajoc_2020_100595 crossref_primary_10_1097_ICU_0000000000000329 crossref_primary_10_1007_s00417_016_3473_0 crossref_primary_10_1371_journal_pone_0166141 crossref_primary_10_3390_ph17030321 crossref_primary_10_1007_s00347_008_1829_5 crossref_primary_10_1002_14651858_CD012131_pub2 crossref_primary_10_1016_j_jcrs_2011_04_014 crossref_primary_10_1016_j_preteyeres_2023_101218 crossref_primary_10_2147_OPTH_S292849 crossref_primary_10_1002_14651858_CD012131_pub3 crossref_primary_10_1024_1661_8157_a003900 crossref_primary_10_1159_000350236 crossref_primary_10_1016_j_ajo_2011_01_004 crossref_primary_10_3390_jpm14070695 crossref_primary_10_1016_j_jcrs_2013_08_036 crossref_primary_10_1111_ceo_13444 crossref_primary_10_1155_2012_313248 crossref_primary_10_1097_ICU_0000000000000216 crossref_primary_10_1016_j_jcrs_2010_03_045 crossref_primary_10_1097_ICB_0000000000000884 crossref_primary_10_1155_2011_243170 crossref_primary_10_1016_j_jcrs_2012_11_003 crossref_primary_10_1016_j_jcrs_2007_07_047 crossref_primary_10_1016_j_oftal_2014_06_003 crossref_primary_10_1016_j_jcrs_2014_09_028 crossref_primary_10_1136_bjo_2021_320588 crossref_primary_10_1016_j_ophtha_2016_01_056 crossref_primary_10_1097_IEB_0b013e3181b95da2 crossref_primary_10_1097_APO_0000000000000208 crossref_primary_10_1111_j_1755_3768_2010_01875_x crossref_primary_10_1586_17469899_3_6_627 crossref_primary_10_1080_09286580802624459 crossref_primary_10_1016_j_ophtha_2019_11_005 crossref_primary_10_1080_17425247_2016_1227785 crossref_primary_10_1017_S095026881400034X crossref_primary_10_3341_jkos_2019_60_5_480 crossref_primary_10_1089_jop_2020_0034 crossref_primary_10_3109_02713683_2012_746991 crossref_primary_10_1128_CMR_00113_16 crossref_primary_10_2147_OPTH_S247739 crossref_primary_10_1097_j_jcrs_0000000000001231 crossref_primary_10_1007_s00417_016_3287_0 crossref_primary_10_16948_zktipb_855520 crossref_primary_10_1007_s10792_014_0011_0 crossref_primary_10_1002_14651858_CD013270 crossref_primary_10_2165_11537950_000000000_00000 |
Cites_doi | 10.1016/S0886-3350(01)01269-X 10.1016/S0886-3350(02)01483-9 10.1016/j.jcrs.2006.07.009 10.1016/j.jcrs.2004.10.057 10.1001/archopht.123.5.613 10.1136/bjo.87.7.867 10.1016/j.ophtha.2005.02.028 10.1016/j.jcrs.2006.02.014 10.1016/S0161-6420(99)90395-0 10.1053/jhin.2001.1050 10.1136/bjo.82.11.1312 10.1136/bjo.88.1.29 10.1016/j.jcrs.2006.02.021 10.1034/j.1600-0420.2002.800305.x 10.1016/j.jcrs.2006.01.065 10.1016/S0161-6420(91)32312-1 10.1111/j.1600-0420.2005.00377.x 10.1016/S0161-6420(91)32053-0 |
ContentType | Journal Article |
Copyright | ASCRS and ESCRS 2007 ASCRS and ESCRS 2007 INIST-CNRS |
Copyright_xml | – notice: ASCRS and ESCRS – notice: 2007 ASCRS and ESCRS – notice: 2007 INIST-CNRS |
CorporateAuthor | Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons |
CorporateAuthor_xml | – name: Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.jcrs.2007.02.032 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-4502 |
EndPage | 988 |
ExternalDocumentID | 10_1016_j_jcrs_2007_02_032 17531690 18837796 S0886335007004609 1_s2_0_S0886335007004609 |
Genre | Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 08R 0R 1- 1B1 1P 1~5 29K 4.4 457 4G. 53G 5GY 5VS 7-5 AAEDT AAGIX AAHPQ AALRI AAQFI AAQKA AAQQT AAQXK AAXUO ABASU ABDIG ABFLS ABIID ABLJU ABMAC ABPTK ACGFO ACGFS ACIUM ADBBV ADPAM AENEX AEVXI AFCTW AFDTB AFRHN AFTJW AGZHU AITUG AJIOK AJUYK AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX ALXNB AMJPA AMKUR AMRAJ ASPBG AVWKF AZFZN BELOY C5W CS3 D-I DIWNM DU5 EBS EJD F5P FDB FEDTE FGOYB FO GBLVA GJ GQDEL HVGLF HZ IHE IKREB IKYAY IPNFZ J1W K K-O KOM L7B M41 MO0 NQ- O9- OF- OPF OQ OVD P2P R2- RIG ROL RPZ SEL SES SJN SSZ TEORI TSPGW UHS UV1 XH2 XPP Z5R ZA5 ZGI ZXP ZZMQN --- --K .1- .FO .GJ 0R~ 1P~ AAEDW AASCR ABJNI ABVCZ ACILI ADGGA ADHPY ADMUD AEETU AHOMT AINUH AJNWD AMNEI C45 EEVPB ERAAH FCALG GNXGY HLJTE HZ~ OQ~ RLZ IQODW AAAAV AAIQE ACXJB AHQNM AKRWK CGR CUY CVF ECM EIF NPM AAYXX AJZMW CITATION 7X8 |
ID | FETCH-LOGICAL-c549t-73f9d5eef7d7e894d5766ee2c91eb893bc5d9a67b4400383be3a93623c404e723 |
ISSN | 0886-3350 |
IngestDate | Fri Aug 16 01:21:01 EDT 2024 Fri Aug 23 01:00:20 EDT 2024 Thu May 23 23:11:05 EDT 2024 Sun Oct 22 16:06:01 EDT 2023 Fri Feb 23 02:31:18 EST 2024 Thu Aug 18 18:34:55 EDT 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Postoperative Cataract Multicenter study Uvea disease Identification Prevention Eye disease Lens disease Treatment Surgery Risk factor Ophthalmology Endophtalmitis Anterior segment disease |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c549t-73f9d5eef7d7e894d5766ee2c91eb893bc5d9a67b4400383be3a93623c404e723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-News-2 ObjectType-Feature-3 content type line 23 |
OpenAccessLink | https://doi.org/10.1016/j.jcrs.2007.02.032 |
PMID | 17531690 |
PQID | 70555173 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_70555173 crossref_primary_10_1016_j_jcrs_2007_02_032 pubmed_primary_17531690 pascalfrancis_primary_18837796 elsevier_sciencedirect_doi_10_1016_j_jcrs_2007_02_032 elsevier_clinicalkeyesjournals_1_s2_0_S0886335007004609 |
PublicationCentury | 2000 |
PublicationDate | 2007-06-01 |
PublicationDateYYYYMMDD | 2007-06-01 |
PublicationDate_xml | – month: 06 year: 2007 text: 2007-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Journal of cataract and refractive surgery |
PublicationTitleAlternate | J Cataract Refract Surg |
PublicationYear | 2007 |
Publisher | Elsevier Inc Elsevier Science |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Science |
References | Kattan, Flynn, Pflugfelder (bib19) 1991; 98 Barry, Seal, Gettinby (bib2) 2006; 32 Nichamin, Chang, Johnson (bib16) 2006; 32 Seal, Barry, Gettinby (bib1) 2006; 32 Taban, Behrens, Newcomb (bib13) 2005; 123 Allardice, Wright, Peterson, Miller (bib18) 2001; 49 Montan, Wejde, Koranyi, Rylander (bib6) 2002; 28 Schmitz, Dick, Krummenauer, Pfeiffer (bib15) 1999; 106 Bainbridge, Teimory, Tabandeh (bib9) 1998; 82 Montan, Lundström, Stenevi, Thorburn (bib12) 2002; 80 West, Behrens, McDonnell (bib14) 2005; 112 Wallin, Parker, Jin (bib5) 2005; 31 Mayer, Cadman, Ewings (bib17) 2003; 87 Menikoff, Speaker, Marmor, Raskin (bib8) 1991; 98 Wejde, Montan, Lundström (bib7) 2005; 83 Foster (bib21) 2000; 13 Nagaki, Hayasaka, Kadoi (bib10) 2003; 29 (bib3) 2005 Mamalis, Edelhauser, Dawson (bib4) 2006; 32 Taylor (bib22) 2000; 84 Wong, Chee (bib11) 2004; 88 Brian, Taylor (bib20) 2001; 79 18165064 - J Cataract Refract Surg. 2008 Jan;34(1):9-10 Barry (R2-24-20210210) 2006; 32 Wong (R11-24-20210210) 2004; 88 Mayer (R17-24-20210210) 2003; 87 Wallin (R5-24-20210210) 2005; 31 Brian (R20-24-20210210) 2001; 79 Allardice (R18-24-20210210) 2001; 49 Kattan (R19-24-20210210) 1991; 98 Foster (R21-24-20210210) 2000; 13 Wejde (R7-24-20210210) 2005; 83 Taban (R13-24-20210210) 2005; 123 Montan (R12-24-20210210) 2002; 80 West (R14-24-20210210) 2005; 112 Menikoff (R8-24-20210210) 1991; 98 Schmitz (R15-24-20210210) 1999; 106 Mamalis (R4-24-20210210) 2006; 32 Seal (R1-24-20210210) 2006; 32 Bainbridge (R9-24-20210210) 1998; 82 Nagaki (R10-24-20210210) 2003; 29 Montan (R6-24-20210210) 2002; 28 Nichamin (R16-24-20210210) 2006; 32 |
References_xml | – volume: 123 start-page: 613 year: 2005 end-page: 620 ident: bib13 article-title: Acute endophthalmitis following cataract surgery; a systematic review of the literature publication-title: Arch Ophthalmol contributor: fullname: Newcomb – volume: 32 start-page: 396 year: 2006 end-page: 406 ident: bib1 article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group publication-title: J Cataract Refract Surg contributor: fullname: Gettinby – volume: 84 start-page: 1 year: 2000 end-page: 2 ident: bib22 article-title: Cataract: how much surgery do we have to do? publication-title: Br J Ophthalmol contributor: fullname: Taylor – volume: 112 start-page: 1388 year: 2005 end-page: 1394 ident: bib14 article-title: The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001 publication-title: Ophthalmology contributor: fullname: McDonnell – volume: 32 start-page: 324 year: 2006 end-page: 333 ident: bib4 article-title: Toxic anterior segment syndrome publication-title: J Cataract Refract Surg contributor: fullname: Dawson – volume: 49 start-page: 23 year: 2001 end-page: 29 ident: bib18 article-title: A statistical approach to an outbreak of endophthalmitis following cataract surgery at a hospital in the West of Scotland publication-title: J Hosp Infect contributor: fullname: Miller – volume: 80 start-page: 258 year: 2002 end-page: 261 ident: bib12 article-title: Endophthalmitis following cataract surgery in Sweden. The 1998 national prospective survey publication-title: Acta Ophthalmol Scand contributor: fullname: Thorburn – volume: 98 start-page: 1761 year: 1991 end-page: 1768 ident: bib8 article-title: A case-control study of risk factors for postoperative endophthalmitis publication-title: Ophthalmology contributor: fullname: Raskin – volume: 88 start-page: 29 year: 2004 end-page: 31 ident: bib11 article-title: Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes publication-title: Br J Ophthalmol contributor: fullname: Chee – volume: 32 start-page: 1556 year: 2006 end-page: 1559 ident: bib16 article-title: ASCRS White Paper. What is the association between clear corneal cataract incisions and postoperative endophthalmitis? publication-title: J Cataract Refract Surgery contributor: fullname: Johnson – volume: 13 start-page: 17 year: 2000 end-page: 19 ident: bib21 article-title: Vision 2020: the cataract challenge publication-title: Comm Eye Health contributor: fullname: Foster – volume: 31 start-page: 735 year: 2005 end-page: 741 ident: bib5 article-title: Cohort study of 27 cases of endophthalmitis at a single institution publication-title: J Cataract Refract Surg contributor: fullname: Jin – volume: 32 start-page: 407 year: 2006 end-page: 410 ident: bib2 article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group publication-title: J Cataract Refract Surg contributor: fullname: Gettinby – volume: 98 start-page: 227 year: 1991 end-page: 238 ident: bib19 article-title: Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery publication-title: Ophthalmology contributor: fullname: Pflugfelder – volume: 83 start-page: 7 year: 2005 end-page: 10 ident: bib7 article-title: Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001 publication-title: Acta Ophthalmol Scand contributor: fullname: Lundström – volume: 82 start-page: 1312 year: 1998 end-page: 1315 ident: bib9 article-title: Intraocular lens implants and risk of endophthalmitis publication-title: Br J Ophthalmol contributor: fullname: Tabandeh – volume: 29 start-page: 20 year: 2003 end-page: 26 ident: bib10 article-title: Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type publication-title: J Cataract Refract Surgery contributor: fullname: Kadoi – volume: 87 start-page: 867 year: 2003 end-page: 869 ident: bib17 article-title: A 10 year retrospective study of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis publication-title: Br J Ophthalmol contributor: fullname: Ewings – volume: 79 start-page: 249 year: 2001 end-page: 256 ident: bib20 article-title: Cataract blindness—challenges for the 21st century publication-title: Bull World Health Organ contributor: fullname: Taylor – volume: 106 start-page: 1869 year: 1999 end-page: 1877 ident: bib15 article-title: Endophthalmitis in cataract surgery; results of a German survey publication-title: Ophthalmology contributor: fullname: Pfeiffer – volume: 28 start-page: 977 year: 2002 end-page: 981 ident: bib6 article-title: Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery publication-title: J Cataract Refract Surg contributor: fullname: Rylander – year: 2005 ident: bib3 article-title: ESCRS Guidelines on Prophylaxis, Management and Therapy of Post-Operative Endophthalmitis, Version 1 – volume: 28 start-page: 977 year: 2002 ident: R6-24-20210210 article-title: Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. publication-title: J Cataract Refract Surg doi: 10.1016/S0886-3350(01)01269-X contributor: fullname: Montan – volume: 29 start-page: 20 year: 2003 ident: R10-24-20210210 article-title: Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type. publication-title: J Cataract Refract Surgery doi: 10.1016/S0886-3350(02)01483-9 contributor: fullname: Nagaki – volume: 32 start-page: 1556 year: 2006 ident: R16-24-20210210 article-title: ASCRS White Paper. What is the association between clear corneal cataract incisions and postoperative endophthalmitis? publication-title: J Cataract Refract Surgery doi: 10.1016/j.jcrs.2006.07.009 contributor: fullname: Nichamin – volume: 31 start-page: 735 year: 2005 ident: R5-24-20210210 article-title: Cohort study of 27 cases of endophthalmitis at a single institution. publication-title: J Cataract Refract Surg doi: 10.1016/j.jcrs.2004.10.057 contributor: fullname: Wallin – volume: 79 start-page: 249 year: 2001 ident: R20-24-20210210 article-title: Cataract blindnesschallenges for the 21st century. publication-title: Bull World Health Organ contributor: fullname: Brian – volume: 123 start-page: 613 year: 2005 ident: R13-24-20210210 article-title: Acute endophthalmitis following cataract surgery; a systematic review of the literature. publication-title: Arch Ophthalmol doi: 10.1001/archopht.123.5.613 contributor: fullname: Taban – volume: 87 start-page: 867 year: 2003 ident: R17-24-20210210 article-title: A 10 year retrospective study of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis. publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.7.867 contributor: fullname: Mayer – volume: 112 start-page: 1388 year: 2005 ident: R14-24-20210210 article-title: The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2005.02.028 contributor: fullname: West – volume: 13 start-page: 17 issue: 34 year: 2000 ident: R21-24-20210210 article-title: Vision 2020: the cataract challenge. publication-title: Comm Eye Health contributor: fullname: Foster – volume: 32 start-page: 396 year: 2006 ident: R1-24-20210210 article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group. publication-title: J Cataract Refract Surg doi: 10.1016/j.jcrs.2006.02.014 contributor: fullname: Seal – volume: 106 start-page: 1869 year: 1999 ident: R15-24-20210210 article-title: Endophthalmitis in cataract surgery; results of a German survey. publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)90395-0 contributor: fullname: Schmitz – volume: 49 start-page: 23 year: 2001 ident: R18-24-20210210 article-title: A statistical approach to an outbreak of endophthalmitis following cataract surgery at a hospital in the West of Scotland. publication-title: J Hosp Infect doi: 10.1053/jhin.2001.1050 contributor: fullname: Allardice – volume: 82 start-page: 1312 year: 1998 ident: R9-24-20210210 article-title: Intraocular lens implants and risk of endophthalmitis. publication-title: Br J Ophthalmol doi: 10.1136/bjo.82.11.1312 contributor: fullname: Bainbridge – volume: 88 start-page: 29 year: 2004 ident: R11-24-20210210 article-title: Risk factors of acute endophthalmitis after cataract extraction: a case-control study in Asian eyes. publication-title: Br J Ophthalmol doi: 10.1136/bjo.88.1.29 contributor: fullname: Wong – volume: 32 start-page: 407 year: 2006 ident: R2-24-20210210 article-title: ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. publication-title: J Cataract Refract Surg doi: 10.1016/j.jcrs.2006.02.021 contributor: fullname: Barry – volume: 80 start-page: 258 year: 2002 ident: R12-24-20210210 article-title: Endophthalmitis following cataract surgery in Sweden. The 1998 national prospective survey. publication-title: Acta Ophthalmol Scand doi: 10.1034/j.1600-0420.2002.800305.x contributor: fullname: Montan – volume: 32 start-page: 324 year: 2006 ident: R4-24-20210210 article-title: Toxic anterior segment syndrome. publication-title: J Cataract Refract Surg doi: 10.1016/j.jcrs.2006.01.065 contributor: fullname: Mamalis – volume: 98 start-page: 227 year: 1991 ident: R19-24-20210210 article-title: Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. publication-title: Ophthalmology doi: 10.1016/S0161-6420(91)32312-1 contributor: fullname: Kattan – volume: 83 start-page: 7 year: 2005 ident: R7-24-20210210 article-title: Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999-2001. publication-title: Acta Ophthalmol Scand doi: 10.1111/j.1600-0420.2005.00377.x contributor: fullname: Wejde – volume: 98 start-page: 1761 year: 1991 ident: R8-24-20210210 article-title: A case-control study of risk factors for postoperative endophthalmitis. publication-title: Ophthalmology doi: 10.1016/S0161-6420(91)32053-0 contributor: fullname: Menikoff |
SSID | ssj0004235 |
Score | 2.4893832 |
Snippet | Purpose To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery... To identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery based on... PURPOSETo identify risk factors and describe the effects of antibiotic prophylaxis on the incidence of postoperative endophthalmitis after cataract surgery... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 978 |
SubjectTerms | Aged Anterior Chamber - drug effects Anti-Bacterial Agents - therapeutic use Antibiotic Prophylaxis Biological and medical sciences Cefuroxime - therapeutic use Endophthalmitis - epidemiology Endophthalmitis - etiology Endophthalmitis - prevention & control Eye Infections, Bacterial - epidemiology Eye Infections, Bacterial - etiology Eye Infections, Bacterial - prevention & control Female Humans Incidence Lens diseases Lens Implantation, Intraocular Levofloxacin Male Medical sciences Odds Ratio Ofloxacin - therapeutic use Ophthalmology Phacoemulsification Postoperative Complications - prevention & control Prospective Studies Risk Factors Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the eye and orbit |
Title | Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0886335007004609 https://dx.doi.org/10.1016/j.jcrs.2007.02.032 https://www.ncbi.nlm.nih.gov/pubmed/17531690 https://search.proquest.com/docview/70555173 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgkxASQtwpl-EH3qpUaWzHCW_TNDQxDaF1E3uzcjkRqrq2alKB-Bn8Ys6xnaQdFAEvUZWb03xf7GP7O58Ze6sziY1uooIoVwl2UJQKEijjAESRVEJHUFjx-NnH-ORSfrhSV70g02aXNPmo-P7bvJL_QRX3Ia6UJfsPyHY3xR34G_HFLSKM27_C-NNqgW9pln1zpiJLMslYgvfyhnmJR5sv2eyafIuGFSK--GpzbLPGujQPa5cTTaMC2Otez5yug0LR48nR-cSpDUm-SZbP1n3aTjWUXmHURZtWn-5X7tkR7XZlWj07VDY5C5-y3kjLbgcfdC-S6uqoOBDCeceOwNWhiRaBVOFWJevcLjyZNmvM1K3g80tN7gYVpqNpsaq902Q0Ct1Y6Aa0y2uLLfmN0oRf36p1WsP20G22H-lUYQd9__D0_PNpnz0buWVY27_iU6ucCvBm8WQy62-4K5K5t8xq_L4qtzDK7p6LjWAuHrD7Hgx-6Hj0kN2C-SN258yLKx6zHxt04ouKb9GJ36AT7-jEW2i5x_Id92SimyCZuCUT3yATt2TiSAW-TSa6gsjEPZmesMv3xxdHJ4FfsiMolEybQIsqLRVApUsNSSpL7M7GAFGRjiHH0DgvVJlmsc6lpDlpkYPIUoyhRCFDCToST9nefDGH54xXstChwhPGpZQihDTBFx-LqIQkynWWDdiwff1m6ZxZTCtZnBrCjZZY1SaMDOI2YLpFyLQ5x9hKQu0_59qMTY1nmgnxgGgQaptYnQ6Y6q70UamLNg1S9Y8lHmwRoX_IJCGXz3jA3rTMMFin00RdNofFujbkcKXGWgzYM0eY_lrPvRc7j7xkd_sP9RXba1ZreI1xc5MfeOL_BAv5yAo |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prophylaxis+of+postoperative+endophthalmitis+following+cataract+surgery%3A+results+of+the+ESCRS+multicenter+study+and+identification+of+risk+factors&rft.jtitle=Journal+of+cataract+and+refractive+surgery&rft.date=2007-06-01&rft.issn=0886-3350&rft.eissn=1873-4502&rft.volume=33&rft.issue=6&rft.spage=978&rft_id=info:doi/10.1016%2Fj.jcrs.2007.02.032&rft_id=info%3Apmid%2F17531690&rft.externalDocID=17531690 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08863350%2FS0886335007X01019%2Fcov150h.gif |